A double-blind, 4-block randomized, placebo-controlled, adaptive phase 2/3 trial to confirm efficacy and safety of BLS-ILB-E710c in patients with cervical intraepithelial neoplasia 2/3 with extension study

被引：0
|
作者：
Ouh, Yung-Taek [1 ]
Song, Seung Hun [2 ]
Kim, Young Tae [3 ]
Cho, Chi-Heum [4 ]
Kim, Tae Jin [5 ]
Min, Seong Su [6 ]
Lee, Do Young [6 ]
Park, Young-Chul [6 ]
Lee, Jae Kwan [7 ]
机构：
[1] Kangwon Natl Univ Hosp, Chuncheon Si, South Korea
[2] Cha Univ, CHA Bundang Med Ctr, Bundang Med Ctr, Seongnam Si, Gyeonggi Do, South Korea
[3] Yonsei Univ, Inst Womens Med Life Sci, Coll Med, Seoul, South Korea
[4] Keimyung Univ, Sch Med, Daegu, South Korea
[5] Konkuk Univ, Sch Med, Seoul, South Korea
[6] BL Corp, Yongin, South Korea
[7] Korea Univ, Guro Hosp, Coll Med, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.208
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1304
引用
收藏
页码：S187 / S188
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [42] Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab
    Zhang, Yanyan
    Pei, Zhaohui
    Chen, Beijian
    Qu, Yanling
    Dong, Xiaolin
    Yu, Binge
    Wang, Guoqin
    Xu, Fang
    Lu, Dongmei
    He, Zhimei
    Chen, Benchao
    Ma, Lei
    Wang, Max
    Li, Baiyong
    Xia, Michelle
    Zheng, Bo
    Huo, Yong
    PHARMACOLOGICAL RESEARCH, 2024, 207
  • [43] Efficacy and Safety of HS-20094 in Patients with Type 2 Diabetes-A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
    Liu, Lin
    Shi, Xiaoxia
    He, Fei
    Cheng, Zhifeng
    Song, Weihong
    Wang, Zhongjing
    Cui, Yimin
    Zhang, Junqing
    DIABETES, 2024, 73
  • [44] A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Mitapivat in Patients with Sickle Cell Disease
    Howard, Joanna
    Kuo, Kevin H. M.
    Oluyadi, Abdulafeez
    Shao, Hui
    Morris, Susan
    Zaidi, Ahmar U.
    Van Beers, Eduard J.
    Thien, Swee Lay
    BLOOD, 2021, 138
  • [45] Efficacy and Safety of Telitacicept in Primary Sjogren's Syndrome: A Randomized, Double-blind, Placebo-controlled, Phase 2 Trial
    Xu, Dong
    Zhang, Shangzhu
    Huang, Cibo
    Huang, Chenghui
    Qin, Li
    Li, Xiaomei
    Chen, Meiqing
    Liu, Xiumei
    Liu, Yi
    Li, Zhijun
    Hu, Jiankang
    Bao, Chunde
    Wei, Wei
    Tian, Jing
    Duan, Xinwang
    Fang, Jianmin
    Zeng, Xiaofeng
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4002 - 4004
  • [46] Efficacy and safety of telitacicept in primary Sjogren's syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial
    Xu, Dong
    Fang, Jianmin
    Zhang, Shangzhu
    Huang, Cibo
    Huang, Chenghui
    Qin, Li
    Li, Xiaomei
    Chen, Meiqing
    Liu, Xiumei
    Liu, Yi
    Li, Zhijun
    Hu, Jiankang
    Bao, Chunde
    Wei, Wei
    Tian, Jing
    Duan, Xinwang
    Zeng, Xiaofeng
    RHEUMATOLOGY, 2024, 63 (03) : 698 - 705
  • [47] A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis
    Peters, Eric
    Chou, Richard C.
    Rozzo, Stephen J.
    Yao, Siu-Long
    Fructuoso, Ferran Jose Garcia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (05) : 223 - 229
  • [48] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Vehreschild, Maria J. G. T.
    Atanasov, Petar
    Yurko, Kateryna
    Oancea, Cristian
    Popov, Georgi
    Smesnoi, Valentina
    Placinta, Gheorghe
    Kohlhof, Hella
    Vitt, Daniel
    Peelen, Evelyn
    Mihajlovic, Jelena
    Muehler, Andreas R.
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2159 - 2176
  • [49] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
    Maria J. G. T. Vehreschild
    Petar Atanasov
    Kateryna Yurko
    Cristian Oancea
    Georgi Popov
    Valentina Smesnoi
    Gheorghe Placinta
    Hella Kohlhof
    Daniel Vitt
    Evelyn Peelen
    Jelena Mihajlović
    Andreas R. Muehler
    Infectious Diseases and Therapy, 2022, 11 : 2159 - 2176
  • [50] Long-Term Vitamin D Supplementation and the Effects on Recurrence and Metabolic Status of Cervical Intraepithelial Neoplasia Grade 2 or 3: A Randomized, Double-Blind, Placebo-Controlled Trial
    Vahedpoor, Zahra
    Mahmoodi, Samaneh
    Samimi, Mansooreh
    Gilasi, Hamid Reza
    Bahmani, Fereshteh
    Soltani, Ali
    Esfahani, Mehran Sharifi
    Asemi, Zatollah
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 (02) : 151 - 160
12345